Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis

Background: There is still a dispute over an issue of the clinical pathology and prognostic of programmed cell death ligand 1 (PD-L1) in hepatocellular carcinoma (HCC) patients. Here, we undertook this meta-analysis to survey the conceivable role of PD-L1 in HCC. Method: We searched databases like M...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing-Hua, Ma, Wei-Jie, Wang, Gang-Gang, Jiang, Xiang, Chen, Xi, Wu, Long, Liu, Zhi-Su, Zeng, Xian-Tao, Zhou, Fu-Ling, Yuan, Yu-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141709/
https://www.ncbi.nlm.nih.gov/pubmed/30254644
http://dx.doi.org/10.3389/fimmu.2018.02077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141709/
https://www.ncbi.nlm.nih.gov/pubmed/30254644
http://dx.doi.org/10.3389/fimmu.2018.02077

Ejemplares similares